Author

D. Bressan

Universidade Federal do Rio de Janeiro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Organism:mouse· 3 Research Focus:clustering· 2 Assay:spatial transcriptomics· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

CRUK IMAXT Grand Challenge Team· 3 shared G. J. Hannon· 3 shared A. Dariush· 2 shared B. Bodenmiller· 2 shared C. M. Mulvey· 2 shared F. Qosaj· 2 shared I. Falciatori· 2 shared L. Kuett· 2 shared

Activity by Year

2021-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

CRUK IMAXT Grand Challenge Team

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Rp-vasa: a bona fide Primordial Germ Cell marker that drives embryonic expression in the Chagas disease vector Rhodnius prolixus

G. Martins, Mateus Berni, Tainan C. Guedes-Silva, D. Bressan, João Vieira, M. Cardoso, Attilio Pane, V. Gantz, Ethan Bier, Helena Marcolla Araujo

The paper identifies Rp-vasa as a primordial germ cell marker in Rhodnius prolixus and demonstrates its utility for gene expression in transgenic approaches.

Current Research in Insect Science · Jan 1, 2026Peer-reviewedDevelopmental Biology

Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer

D. De Felice, A. Alaimo, D. Bressan, S. Genovesi, E. Marmocchi, N. Annesi, G. Beccaceci, D. Dalfovo, F. Cutrupi, V. Foletto, M. Lorenzoni, F. Gandolfi, S. Kannan, C. S. Verma, A. Vasciaveo, , A. Lunardi

This study shows RA signaling promotes luminal identity in prostate progenitors through Foxa1, and identifies a loss-of-function mutation in Foxa1 linked to prostate cancer dedifferentiation.

bioRxiv · Mar 6, 2024Cancer Biology

Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.

S. A. Wild, I. G. Cannell, K. Kania, A. Nicholls, D. Bressan, CRUK IMAXT Grand Challenge Team, G. J. Hannon, K. Sawicka

The paper uses clonal transcriptomics to identify mechanisms of chemoresistance in TNBC and suggests asparagine deprivation as a potential combination therapy.

bioRxiv · Dec 9, 2021Cancer Biology

Exploration and analysis of molecularly annotated, 3D models of breast cancer at single-cell resolution using virtual reality

D. Bressan, C. M. Mulvey, F. Qosaj, R. Becker, F. Grimaldi, S. Coffey, S. L. Vogl, L. Kuett, R. Catena, A. Dariush, C. Gonzalez Fernandez, E. A. Gonzalez Solares, M. Al Sa'd, A. Küpkü Yoldas, T. Whitmarsh, , G. J. Hannon

The paper introduces Theia, a virtual reality platform for exploring 3D molecularly annotated cancer datasets, and provides breast cancer datasets for analysis.

bioRxiv · Jun 28, 2021 · PreprintCancer Biology

The Imaging and Molecular Annotation of Xenografts and Tumours (IMAXT) High Throughput Data and Analysis Infrastructure

E. A. Gonzalez-Solares, A. Dariush, C. Gonzalez-Fernandez, A. Küpcü Yoldas, M. Al Sa'd, N. Millar, T. Whitmarsh, N. Chornay, I. Falciatori, A. Fatemi, D. Goodwin, L. Kuett, C. M. Mulvey, M. Paez Ribes, F. Qosaj, , N. A. Walton

The paper presents an infrastructure for high-throughput data and analysis of tumour and xenograft samples using multimodal imaging and molecular annotation.

bioRxiv · Jun 22, 2021Cancer Biology